|
The company said that excluding impact of one-time items in the quarter, PAT was up 15% as compared with a year ago. The profit growth is led by product price-mix, productivity, and moderating cost inflation as against the base period.
Revenue from operations fell marginally to Rs 1,130.93 crore in Q3 FY24 as compared with Rs 1,134.24 crore in corresponding quarter last year.
Profit before tax stood at Rs 308.51 crore in Q3 FY24, registering the growth of 9.58% on YoY basis.
LV Vaidyanathan, managing directorof P&G Hygiene and Health Care said, “The quarter has remained challenging amidst a difficult operating environment. We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority - across product performance, packaging, brand communication, retail execution and consumer and customer value - productivity, constructive disruption, and an agile and accountable organization. We are confident that these strategies will help us navigate the mid-term and deliver balanced growth and value creation.”
Meanwhile, the board has declared an interim dividend of Rs 160 per equity share, which includes a one-time special dividend of Rs 60 per equity share for the financial year 2023-24.
Procter & Gamble Hygiene & Healthcare is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses.
Shares of Procter & Gamble Hygiene & Health Care fell 0.03% to currently trade at Rs 17,160 on the BSE.
|